HTA64 Characteristics of Cell and Gene Therapies Authorized By the Food and Drug Administration and the European Medicines Agency
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1415
https://www.valueinhealthjournal.com/article/S1098-3015(24)01530-4/fulltext
Title :
HTA64 Characteristics of Cell and Gene Therapies Authorized By the Food and Drug Administration and the European Medicines Agency
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01530-4&doi=10.1016/j.jval.2024.03.1415
First page :
Section Title :
Open access? :
No
Section Order :
10804